Scarica l'app Stockscreener
34.46
4.38%
-1.58
Dopo l'orario di chiusura:
33.67
-0.79
-2.29%
Precedente Chiudi:
$36.04
Aprire:
$37.07
Volume 24 ore:
1.04M
Relative Volume:
0.65
Capitalizzazione di mercato:
$1.23B
Reddito:
Utile/perdita netta:
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
1 W Prestazione:
+8.19%
1M Prestazione:
-11.64%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$33.38
$37.24
Intervallo di 1 settimana:
$30.88
$40.50
Portata 52W:
$14.72
$49.91
First Tracks Biotherapeutics Inc Stock (TRAX) Company Profile
Nome
First Tracks Biotherapeutics Inc
Settore
Industria
Telefono
212-373-3000
Indirizzo
10770 WATERIDGE CIRCLE, SAN DIEGO
Compare TRAX vs VRTX, MRNA, REGN, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TRAX
First Tracks Biotherapeutics Inc
|
34.46 | 1.23B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
First Tracks Biotherapeutics Inc Stock (TRAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-09-30 | Iniziato | Canaccord Genuity | Buy |
| 2026-09-18 | Iniziato | Evercore ISI | Outperform |
| 2026-09-16 | Iniziato | Guggenheim | Buy |
| 2026-08-18 | Iniziato | Wolfe Research | Outperform |
| 2026-06-08 | Iniziato | Wells Fargo | Overweight |
| 2026-05-04 | Iniziato | Piper Sandler | Overweight |
| 2026-04-28 | Iniziato | H.C. Wainwright | Buy |
| 2026-04-24 | Iniziato | Leerink Partners | Outperform |
| 2026-04-24 | Iniziato | Wedbush | Outperform |
| 2026-04-23 | Iniziato | JP Morgan | Overweight |
| 2026-04-22 | Iniziato | Barclays | Overweight |
| 2026-04-21 | Iniziato | UBS | Buy |
Mostra tutto
First Tracks Biotherapeutics Inc Borsa (TRAX) Ultime notizie
First Tracks Biotherapeutics raises $200 million in private placement at $32.75 per share - Minichart
First Tracks Biotherapeutics Secures $200 Million Private Placement at $32.75 Per Share - TradingView
First Tracks Biotherapeutics Targets About $200 Million in Placement - TOKENPOST
First Tracks Biotherapeutics Announces $200 Million Private Placement - GlobeNewswire
First Tracks Biotherapeutics (TRAX) Stock Looks Rich Following Phase 1b Celiac Data - Yahoo Finance
Breaking News about First Tracks Biotherapeutics, Inc.Ordinary Shares (Nasdaq:TRAX) - FinancialContent
Markets & StocksFirst Tracks Biotherapeutics, Inc.Ordinary Shares (Nasdaq:TRAX) Stock Quote - FinancialContent
First Tracks Biotherapeutics Inc (TRAX) Stock Price, Quote, News & History - benzinga.com
John Orwin (TRAX) lifts direct stake to 17,995 shares - Stock Titan
Basic earnings per share (basic EPS) of First Tracks Biotherapeutics Inc – FWB:B43 - TradingView
First Tracks Biotherapeutics Inc Cash Flow – FWB:B43 - TradingView
ETFs Investing in First Tracks Biotherapeutics Inc Stocks - tradingview.com
First Tracks Biotherapeutics at wells fargo healthcare conference: data loom By Investing.com - Investing.com South Africa
First Tracks Biotherapeutics at wells fargo healthcare conference: data loom By Investing.com - Investing.com Canada
First Tracks Biotherapeutics Insider Ware J. Anthony Sells 39,265 Shares at $44.78 Following Option Exercise - Kalkine Media
First Tracks Biotherapeutics Director Sold Shares Worth Over $1.7M - TradingView
First Tracks Biotherapeutics (TRAX) director sells shares after option exercise - Stock Titan
TRAX Reiterates by First Tracks -- Price Target Maintained at $5 - GuruFocus
H.C. Wainwright Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $57 - Moomoo
Long term debt to total assets ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Which stocks are gapping on Wednesday? - ChartMill
Million-dollar insider sale at First Tracks (NASDAQ: TRAX) after option exercise - Stock Titan
Cash flow from operating activities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
EBIT per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Revenue per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Return on assets % of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Total debt of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
After tax other income/expense of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics Announces Participation in September Investor Conferences - Yahoo Finance
Non-controlling/minority interest of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Total liabilities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Taxes of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Diluted shares outstanding of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Total operating expenses of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Diluted earnings per share (diluted EPS) of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
First Tracks Biotherapeutics, Inc. Revenue Breakdown – NASDAQ:TRAX - TradingView
Total revenue of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
Dilution adjustment of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Price to cash flow ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
CapEx per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Number of shareholders of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Enterprise value to EBITDA forward of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
Net debt of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Gross profit of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
EBIT of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Net current asset value per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Free cash flow of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Total liabilities & shareholders' equities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Non-operating income (total) of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Enterprise value to EBITDA ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics Inc Azioni (TRAX) Dati Finanziari
Non sono disponibili dati finanziari per First Tracks Biotherapeutics Inc (TRAX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
First Tracks Biotherapeutics Inc Azioni (TRAX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Ware J. Anthony | Director |
Sep 02 '26 |
Option Exercise |
5.74 |
39,265 |
225,381 |
54,925 |
| Ware J. Anthony | Director |
Sep 02 '26 |
Sale |
44.78 |
39,265 |
1,758,145 |
15,660 |
| JOE ANTHONY WARE | Director |
Sep 02 '26 |
Proposed Sale |
44.78 |
39,265 |
1,758,145 |
0 |
| Ware J. Anthony | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
6,030 |
0 |
15,660 |
| Jain Rita | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
7,330 |
0 |
19,194 |
| FENTON DENNIS M | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
6,030 |
0 |
10,995 |
| Marquet Magda | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
6,030 |
0 |
15,960 |
| Schmid John P. | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
6,030 |
0 |
37,652 |
| Orwin John A | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
6,030 |
0 |
16,695 |
5.14%
0.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):